On ECHEMI
Home > Drugs > Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd.
Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd.
  • Founded in:

    1998-12-30
  • Country:

    China China
  • Address:

    South side of Dongshan, Jinshanqiao Development Zone, Xuzhou City, Jiangsu Province
  • Tax NO.:

    91320300714139872F
  • Registered Funds:

    480.4554 million yuan
  • Website:

  • Email:

Related Drugs
Recombinant human insulin injection
The main components of this product are: recombinant human insulin.
Name Description Content CAS NO. Registered Holders
INSULIN

It can regulate sugar metabolism, promote the uptake and utilization of glucose by the liver, bones and adipose tissue, promote the conversion of glucose into glycogen and storage in muscles and liver, and inhibit gluconeogenesis, thereby lowering blood sugar.

More

It can regulate sugar metabolism, promote the uptake and utilization of glucose by the liver, bones and adipose tissue, promote the conversion of glucose into glycogen and storage in muscles and liver, and inhibit gluconeogenesis, thereby lowering blood sugar.

11061-68-0 11
Recombinant human insulin injection
The main components of this product are: recombinant human insulin.
Name Description Content CAS NO. Registered Holders
INSULIN

Regulates sugar metabolism, promotes the uptake and utilization of glucose by the liver, bones and adipose tissue, promotes the conversion of glucose into glycogen and storage in muscles and liver, and inhibits gluconeogenesis, thereby lowering blood sugar.

More

Regulates sugar metabolism, promotes the uptake and utilization of glucose by the liver, bones and adipose tissue, promotes the conversion of glucose into glycogen and storage in muscles and liver, and inhibits gluconeogenesis, thereby lowering blood sugar.

11061-68-0 11
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.